Reuters
22 Jun 2026, 09:24 UTC · 3h ago
Baker Hughes offers remedies to obtain EU nod for Chart deal
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Reuters
22 Jun 2026, 09:24 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
Baker Hughes has offered remedies to the European Commission to secure antitrust approval for its $13.6 billion acquisition of Chart Industries. — Offering remedies increases the probability of a deal closing, which typically supports the valuation of the target company and reduces regulatory uncertainty.
+0.40Which stocks this story touches
Baker Hughes is actively offering remedies to clear regulatory hurdles for a strategic acquisition.
Chart Industries is the target of a multi-billion dollar acquisition that is moving toward EU approval.
Continue reading
6 related stories
Search tags
[a_to_b] Baker Hughes is seeking antitrust approval for its $13.6 billion acquisition of Chart Industries.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
New York Post
1d ago
